Moclobemide Response in Depressed Patients: Association Study with a Functional Polymorphism in the Monoamine Oxidase A Promoter

D. J. Müller; T. G. Schulze; F. Macciardi; S. Ohlraun; M. M. Gross; H. Scherk; H. Neidt; Y. V. Syagailo; M. Grässle; M. M. Nöthen; W. Maier; K.-P. Lesch; M. Rietschel

doi:10.1055/s-2002-33199

Pharmacopsychiatry 2002; 35(4): 157-158
DOI: 10.1055/s-2002-33199

Short Communication

Moclobemide Response in Depressed Patients: Association Study with a Functional Polymorphism in the Monoamine Oxidase A Promoter

D. J. Müller¹ , T. G. Schulze^1, ² , F. Macciardi³ , S. Ohlraun¹ , M. M. Gross¹ , H. Scherk¹ , H. Neidt⁴ , Y. V. Syagailo⁵ , M. Grässle⁵ , M. M. Nöthen⁶ , W. Maier¹ , K.-P. Lesch⁵ , M. Rietschel¹

¹Department of Psychiatry, University of Bonn, Germany
²Department of Psychiatry, The University of Chicago, USA
³Centre for Addiction and Mental Health (CAMH), University of Toronto, Canada
⁴Institute of Human Genetics, University of Bonn, Germany
⁵Department of Psychiatry, University of Würzburg, Germany
⁶Department of Medical Genetics, University of Antwerp, Belgium

The study was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 400). DJM was a recipient of a post-doctoral fellowship granted by the Research Support Program of the University of Bonn (BONFOR). TGS was a recipient of a post-doctoral fellowship from Deutsche Forschungsgemeinschaft (GK 246 Pathogenese von Erkrankungen des Nervensystems). This study was supported by the German Research Ministry within the promotional emphasis “Networks of Competence in Medicine”.

Abstract

Full Text

References

1 American Psychiatric Association 1994: Diagnostic and statistical manual of mental disorders. Fourth edition. American Psychiatric Association Washington DC; 1994
2 Casacchia M, Carolei A, Barba C, Frontoni M, Rossi A, Meco G, Zylberman M R. A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor. Pharmacopsychiat. 1984; 17 122-125
3 Deckert J, Catalano M, Syagailo Y V, Bosi M, Okladnova O, Di Bella D,. et al . Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet. 1999; 8 621-624
4 Endicott J, Spitzer R L. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 1978; 35 837-844
5 Mannuzza S, Fyer A J, Endicott J, Klein D F. Family Informant Schedule and Criteria (FISC). New York; Anxiety Disorder Clinic, New York State Psychiatric Institute 1985
6 McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry. 1991; 48 764-770
7 Parker G. Classifying depression: should paradigms lost be regained?. Am J Psychiatry. 2000; 157 1195-1203
8 Sabol S Z, Hu S, Hamer D S. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet. 1998; 103 273-279
9 Schulze T G, Müller D J, Krauss H, Scherk H, Ohlraun S, Syagailo Y V,. et al . Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet (Neuropsych Genet). 2000; 96 801-803
10 Stassen H H, Angst J, Delini-Stula A. Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement. Pharmacopsychiat. 1999; 32 56-60

Dr. med. Daniel J. Müller

Department of Psychiatry

University of Bonn

Sigmund-Freud-Str. 25

53105 Bonn

Germany

Phone: ++49 228 287 5685

Fax: ++49 228 287 4471

Email: d.mueller@uni-bonn.de